GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $334,000 | -13.5% | 7,623 | -12.9% | 0.00% | 0.0% |
| Q1 2022 | $386,000 | -6.3% | 8,757 | -5.3% | 0.00% | 0.0% |
| Q4 2021 | $412,000 | +16.7% | 9,245 | +1.4% | 0.00% | -20.0% |
| Q3 2021 | $353,000 | +47.7% | 9,119 | +54.0% | 0.01% | +66.7% |
| Q2 2021 | $239,000 | -28.0% | 5,922 | -36.3% | 0.00% | -40.0% |
| Q1 2021 | $332,000 | -0.3% | 9,299 | +4.2% | 0.01% | 0.0% |
| Q4 2020 | $333,000 | -26.5% | 8,924 | -24.8% | 0.01% | -37.5% |
| Q3 2020 | $453,000 | -24.6% | 11,866 | -18.2% | 0.01% | -38.5% |
| Q2 2020 | $601,000 | +138.5% | 14,502 | +124.9% | 0.01% | +62.5% |
| Q1 2020 | $252,000 | -60.8% | 6,449 | -52.4% | 0.01% | -52.9% |
| Q4 2019 | $643,000 | +11.6% | 13,539 | +1.3% | 0.02% | -5.6% |
| Q3 2019 | $576,000 | +79.4% | 13,364 | +76.5% | 0.02% | +50.0% |
| Q1 2019 | $321,000 | +101.9% | 7,570 | +84.1% | 0.01% | +33.3% |
| Q4 2018 | $159,000 | – | 4,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |